Persson; Roy

Patent Applications and Registrations

Patent applications and USPTO patent grants for Persson; Roy.The latest application filed is for "immunizing against hiv infection".

Company Profile

0.12.7

Persson; Roy - Toronto CA
Persson; Roy - North York CA
Persson, Roy - Toronto Ontario CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immunizing Against HIV Infection App 20090142373 - Rovinski; Benjamin ; et al.	2009-06-04
Retrovirus-like particles made non-infectious by a plurality of mutations Grant 7,229,625 - Rovinski , et al. June 12, 2	2007-06-12
Expressing gp140 fragment of primary HIV-1 isolate Grant 7,220,826 - Sia , et al. May 22, 2	2007-05-22
Pneumolysin derivatives App 20060257421 - Ochs; Martina ; et al.	2006-11-16
Immunizing against HIV infection App 20050287174 - Rovinski, Benjamin ; et al.	2005-12-29
Retrovirus-like particles made non-infectious by a plurality of mutations App 20050271687 - Rovinski, Benjamin ; et al.	2005-12-08
Retrovirus-like particles made non-infectious by a plurality of mutations Grant 6,923,970 - Rovinski , et al. August 2, 2	2005-08-02
Immunizing against hiv infection App 20040013684 - Rovinski, Benjamin ; et al.	2004-01-22
Retrovirus-like particles made non-infectious by a plurality of mutations App 20030165535 - Rovinski, Benjamin ; et al.	2003-09-04
Non-infectious, immunogenic, human immunodeficiency virus-like particles devoid of long terminal repeats and a functional pol coding region Grant 6,544,527 - Rovinski , et al. April 8, 2	2003-04-08
Immunizing against HIV infection App 20020051770 - Rovinski, Benjamin ; et al.	2002-05-02
Antigenically-marked non-infectious retrovirus-like particles Grant 6,291,157 - Rovinski , et al. September 18, 2	2001-09-18
Vectors for DNA immunization against cervical cancer Grant 6,235,523 - Gajewczyk , et al. May 22, 2	2001-05-22
Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles Grant 6,080,408 - Rovinski , et al. June 27, 2	2000-06-27
Methods for the detection of HIV-specific immune responses employing non-infectious, non-replicating, IIV retrovirus-like particles containing heterologous antigenic markers Grant 6,025,125 - Rovinski , et al. February 15, 2	2000-02-15
Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region Grant 5,955,342 - Rovinski , et al. September 21, 1	1999-09-21
Nucleic acid molecules encoding non-infectious, non-replicating, HIV retrovirus-like particles containing heterologous antigenic anchor sequences Grant 5,889,176 - Rovinski , et al. March 30, 1	1999-03-30
Genetically engineered human immunodeficiency virus-like particles with modified chimeric envelope glycoproteins containing influenza virus transmembrane spanning domains Grant 5,879,925 - Rovinski , et al. March 9, 1	1999-03-09
Nucleic acids encoding for non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region Grant 5,866,320 - Rovinski , et al. February 2, 1	1999-02-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.